27
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Haemolytic Properties of Pluronic Surfactants and Effects of Purification

, &
Pages 135-139 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

C. M. Edwards, K. C. Lowe, H. Trabelsi, P. Lucas & A. Cambon. (1997) Novel Fluorinated Surfactants for Perfluorochemical Emulsification: Biocompatibility Assessments of Glycosidic and Polyol Derivatives. Artificial Cells, Blood Substitutes, and Biotechnology 25:3, pages 327-333.
Read now

Articles from other publishers (18)

Lukas Bollenbach, Julia Buske, Karsten Mäder & Patrick Garidel. (2022) Poloxamer 188 as surfactant in biological formulations – An alternative for polysorbate 20/80?. International Journal of Pharmaceutics 620, pages 121706.
Crossref
Gabriela Corrêa Carvalho, Victor Hugo Sousa Araujo, Bruno Fonseca-Santos, Jennifer Thayanne Cavalcante de Araújo, Maurício Palmeira Chaves de Souza, Jonatas Lobato Duarte & Marlus Chorilli. (2021) Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. International Journal of Pharmaceutics 602, pages 120635.
Crossref
Lisa Sanderson, Marcelo da Silva, Gayathri N. Sekhar, Rachel C. Brown, Hollie Burrell-Saward, Mehmet Fidanboylu, Bo Liu, Lea Ann Dailey, Cécile A. Dreiss, Chris Lorenz, Mark Christie, Shanta J. Persaud, Vanessa Yardley, Simon L. Croft, Margarita Valero & Sarah A. Thomas. (2021) Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug. PLOS Neglected Tropical Diseases 15:4, pages e0009276.
Crossref
Mohammed S. Alqahtani, Rabbani Syed & Meshal Alshehri. (2020) Size-Dependent Phagocytic Uptake and Immunogenicity of Gliadin Nanoparticles. Polymers 12:11, pages 2576.
Crossref
Owen Green & Guy Healing. 2013. Non-Clinical Vascular Infusion Technology, Volume I. Non-Clinical Vascular Infusion Technology, Volume I 115 154 .
J.C. Bode, J. Kuntsche, S.S. Funari & H. Bunjes. (2013) Interaction of dispersed cubic phases with blood components. International Journal of Pharmaceutics 448:1, pages 87-95.
Crossref
Agnes Schulze, Manfred F. Maitz, Ralf Zimmermann, Barbara Marquardt, Marion Fischer, Carsten Werner, Marco Went & Isabell Thomas. (2013) Permanent surface modification by electron-beam-induced grafting of hydrophilic polymers to PVDF membranes. RSC Advances 3:44, pages 22518.
Crossref
Kristóf Kovács, István Antal, György Stampf, Imre Klebovich & Krisztina Ludányi. (2010) Composition Optimization and Stability Testing of a Parenteral Antifungal Solution based on a Ternary Solvent System. AAPS PharmSciTech 11:1, pages 285-293.
Crossref
X. Zhao, J.M. Courtney & H. Qian. 2010. Biomaterials and Devices for the Circulatory System. Biomaterials and Devices for the Circulatory System 24 53 .
. (2008) Safety Assessment of Poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, Poloxamer 105 Benzoate, and Poloxamer 182 Dibenzoate as Used in Cosmetics. International Journal of Toxicology 27:2_suppl, pages 93-128.
Crossref
Tatiana Demina, Irina Grozdova, Oxana Krylova, Artem Zhirnov, Vladislav Istratov, Holger Frey, Holger Kautz & Nikolay Melik-Nubarov. (2005) Relationship between the Structure of Amphiphilic Copolymers and Their Ability To Disturb Lipid Bilayers. Biochemistry 44:10, pages 4042-4054.
Crossref
Christopher G. Earnhart & Stephen L. Kaattari. (2003) The humoral response to in vitro generated parasite antigens is enhanced by the removal of a defined media component prior to immunization. Journal of Immunological Methods 278:1-2, pages 67-78.
Crossref
J. Michael Grindel, Ted Jaworski, Olga Piraner, R. Martin Emanuele & M. Balasubramanian. (2002) Distribution, Metabolism, and Excretion of a Novel Surface‐Active Agent, Purified Poloxamer 188, in Rats, Dogs, and Humans. Journal of Pharmaceutical Sciences 91:9, pages 1936-1947.
Crossref
J. Michael Grindel, Ted Jaworski, R. Martin Emanuele & Paula Culbreth. (2002) Pharmacokinetics of a novel surface‐active agent, purified poloxamer 188, in rat, rabbit, dog and man. Biopharmaceutics & Drug Disposition 23:3, pages 87-103.
Crossref
S.H. Yalkowsky, J.F. Krzyzaniak & G.H. Ward. (1998) Formulation-Related Problems Associated with Intravenous Drug Delivery. Journal of Pharmaceutical Sciences 87:7, pages 787-796.
Crossref
Joseph F. Krzyzaniak, Fernando A. Alvarez Núñez, Dawn M. Raymond & Samuel H. Yalkowsky. (1997) Lysis of Human Red Blood Cells. 4. Comparison of in Vitro and in Vivo Hemolysis Data. Journal of Pharmaceutical Sciences 86:11, pages 1215-1217.
Crossref
Joseph F Krzyzaniak, Dawn M Raymond & Samuel H Yalkowsky. (1997) Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. International Journal of Pharmaceutics 152:2, pages 193-200.
Crossref
C. M. Edwards, K. C. Lowe, S. Heptinstall, P. Lucas, H. Trabelsi & A. Cambon. 1997. Oxygen Transport to Tissue XIX. Oxygen Transport to Tissue XIX 489 493 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.